102 signals · alpha_vantage, bluesky, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Elevated risk signals — operational or reputational pressure patterns observed.
Auto-generated from public signals — AI summary pending. Based on 3 recent signals.
RBC Capital maintains Outperform rating on Johnson & Johnson, $290 price target TradingView
Johnson & Johnson wins trial over Massachusetts woman’s talc lawsuit The Black Chronicle
Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss Benzinga
Medical devices, pharmaceuticals, and consumer health.
Based on 102 signals across 3 sources · snapshot 7 Oct 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Johnson & Johnson is mixed based on public signals as of 7 Oct 2026.
Based on 102 signals across 3 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.